BACARDI-LIMITED
Bacardi Limited, the largest privately held spirits company in the world, announces 20-year Bacardi veteran Mahesh Madhavan takes over the chief executive leadership role effective immediately. As announced in March, Madhavan succeeds Michael J. Dolan, who has retired as chief executive officer (CEO), a role he held since 2014. Madhavan will be based in the company’s global headquarters in Bermuda.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171002005280/en/
“With more than 20 years at Bacardi, in different roles in different geographies, Mahesh has a tremendous track record of success. He inherits a business that is in great shape, with a healthy balance sheet, revitalized brands, and an engaged team of employees. Mike and Mahesh have worked closely to carry out the succession smoothly, and the Board is delighted with the progress they achieved,” says Facundo L. Bacardi, Chairman of family-owned Bacardi Limited.
In his career with Bacardi, Madhavan has led the company’s Europe, Asia, Middle East & Africa operations where he was charged with building stronger connections between the iconic brands in the Bacardi portfolio and consumers in those regions. Also during his tenure, Madhavan has held leading roles in various fast-growing emerging markets including Managing Director of India, Managing Director for Thailand and the Philippines, and Managing Director of South Asia and Southeast Asia. He has also led the company’s Emerging Market Council.
Global Leadership Team Additions
As part of this leadership succession plan, Madhavan announces the internal appointments of two senior leaders. Effective immediately, John Burke, 51, assumes responsibility for leading all marketing efforts as Global Chief Marketing Officer (CMO) of Bacardi and President of Bacardi Global Brands Limited, while Ignacio del Valle, 47, leads commercial operations for the Latin America & Caribbean region as its Regional President. Burke and del Valle serve as members of the Bacardi Global Leadership Team and report directly to Madhavan.
John Burke has spent more than two decades in various leadership roles within Bacardi. Burke will provide leadership and strategic direction for Bacardi’s global marketing organization, which had been led by Dolan in recent years. He will be based between the Bacardi global headquarters in Bermuda, subject to Bermuda immigration approval, and Bacardi Global Brands Limited’s London office. Burke has achieved notable success during a more than 24-year career at Bacardi. He has had diverse experience working in country operations, regional and global sales and marketing, including as the lead for core brands in the Bacardi portfolio including BACARDÍ®, BOMBAY SAPPHIRE®, MARTNI®, and DEWAR’S®, and most recently as president of Incubation Brands charged with building brand equity in the fastest-growing premium brands in the portfolio including ANGEL'S ENVY®, ST-GERMAIN®, BANKS®, SANTA TERESA®, and LEBLON®.
Ignacio del Valle has been promoted to Regional President - Latin America & Caribbean. Del Valle is responsible for leading commercial operations in the region for the company’s portfolio of premium spirits. A 21-year veteran of Bacardi, del Valle understands the region extremely well, having spent his entire career at Bacardi working in Latin America & Caribbean across different markets and functions. During his tenure, he has developed a deep understanding of the industry and route-to-market models, while building strong relationships with key distributors. For more than 15 years he has served on the regional leadership team in commercial and production roles including country manager for Central America and managing director for South America. He most recently led the Caribbean, Central America, and the Andean countries of Colombia, Ecuador, and Venezuela. Del Valle will remain based in Panama. Del Valle succeeds Constantino Spas who has decided to pursue opportunities outside of the company. The company thanks Spas, a true connoisseur of the drinks business, for his leadership at Bacardi driving commercial ventures and a new focus on digital innovation in the region.
“These internal appointments showcase our deep bench of seasoned talent and leadership within Bacardi and further demonstrates the company’s dedication to nurturing and growing our talented leaders,” adds Madhavan.
About Bacardi Limited
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S®, ERISTOFF® vodka, and ST-GERMAIN® elderflower liqueur.
Founded more than 155 years ago, in Santiago de Cuba on February 4, 1862, family-owned Bacardi employs nearly 5,500 and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. www.bacardilimited.com
NOTE : Headshots of Madhavan, Burke, and del Valle are available via www.BacardiLimited.com and BusinessWire.
©2017 BACARDI
BACARDI, THE BAT DEVICE & OTHER MARKS RELATED TO PRODUCTS IN THIS NEWS RELEASE ARE TRADEMARKS OF
BACARDI & COMPANY LIMITED OR OF OTHER SUBSIDIARIES OF BACARDI LIMITED
View source version on businesswire.com: http://www.businesswire.com/news/home/20171002005280/en/
Contact:
Bacardi Limited
Amy Federman, +1 441-294-1110
afederman@bacardi.com
or
K.C.
Kavanagh, +1 441-298-1053
kckavanagh@bacardi.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom